HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tara A McCannel Selected Research

Iodine-125

1/2022Extrascleral extension of choroidal melanoma after iodine-125 brachytherapy treatment: a case series.
1/2020Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.
12/2018NEW ULTRA-WIDE-FIELD ANGIOGRAPHIC GRADING SCHEME FOR RADIATION RETINOPATHY AFTER IODINE-125 BRACHYTHERAPY FOR UVEAL MELANOMA.
3/2018Outcomes of cataract surgery in eyes with ocular melanoma treated with iodine-125 brachytherapy.
12/2017Comparison of Gene Expression Profiling and Chromosome 3 Analysis by Fluorescent in situ Hybridization and Multiplex Ligation Probe Amplification in Fine-Needle Aspiration Biopsy Specimens of Uveal Melanoma.
9/2017Juxtapapillary and circumpapillary choroidal melanoma: globe-sparing treatment outcomes with iodine-125 notched plaque brachytherapy.
7/2017VITRECTOMY-ASSISTED BIOPSY FOR MOLECULAR PROGNOSTICATION OF CHOROIDAL MELANOMA 2 MM OR LESS IN THICKNESS WITH A 27-GAUGE CUTTER.
1/2017Diagnosis of Choroidal Melanoma in Dense Asteroid Hyalosis.
12/201623-mm iodine-125 plaque for uveal melanoma: benefit of vitrectomy and silicone oil on visual acuity.
7/2016Tumor-height regression rate after brachytherapy between choroidal melanoma gene expression profile classes: effect of controlling for tumor height.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tara A McCannel Research Topics

Disease

27Melanoma (Melanoma, Malignant)
01/2022 - 05/2009
22Neoplasms (Cancer)
01/2020 - 10/2009
13Uveal melanoma
01/2020 - 07/2010
6Retinal Detachment (Retinal Detachments)
01/2022 - 01/2009
3Macular Degeneration (Age-Related Maculopathy)
03/2018 - 05/2009
3Neoplasm Metastasis (Metastasis)
12/2016 - 01/2011
2Glaucoma
01/2020 - 01/2016
2Monosomy
01/2013 - 11/2011
1Open-Angle Glaucoma (Glaucoma, Open Angle)
01/2020
1Pseudophakia
01/2020
1Neovascular Glaucoma
01/2020
1Retinal Neovascularization
12/2018
1Vascular System Injuries
12/2018
1von Hippel-Lindau Disease (von Hippel Lindau Disease)
04/2018
1Hemangioblastoma
04/2018
1Cataract (Cataracts)
03/2018
1Strabismus (Squint)
08/2017
1Adenocarcinoma of Lung
12/2016
1Hyphema
01/2016
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2015
1Uveitis
08/2014
1Central Serous Chorioretinopathy
08/2014
1Hemangioma (Angioma)
05/2013
1Endophthalmitis (Ophthalmia)
03/2012
1Chromosome Aberrations (Chromosome Abnormalities)
05/2011
1Cavernous Hemangioma (Cavernous Angioma)
09/2010
1Central Nervous System Cavernous Hemangioma
09/2010
1AIDS-Related Complex (ARC)
07/2010
1Diarrhea
10/2009
1Hypophysitis
10/2009
1Macular Edema
05/2009
1Adenoma (Adenomas)
01/2009
1Choroidal Effusions
01/2009

Drug/Important Bio-Agent (IBA)

18Iodine-125IBA
01/2022 - 01/2011
6Fluorescein (Funduscein)FDA LinkGeneric
01/2020 - 01/2009
6IodineIBA
09/2017 - 07/2010
5Silicone OilsIBA
01/2020 - 07/2010
4Retinaldehyde (Retinal)IBA
04/2018 - 01/2009
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2014 - 04/2012
2Peptides (Polypeptides)IBA
05/2014 - 10/2009
2Biological ProductsIBA
01/2013 - 09/2010
2RNA (Ribonucleic Acid)IBA
02/2011 - 09/2010
1Phosphotransferases (Kinase)IBA
10/2019
1ParaffinIBA
01/2018
1ElementsIBA
01/2017
1SiliconesIBA
01/2017
1EnzymesIBA
08/2014
1Adrenal Cortex Hormones (Corticosteroids)IBA
08/2014
1Mitogen-Activated Protein KinasesIBA
08/2014
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2014
1VaccinesIBA
05/2014
1HeliumIBA
07/2013
1PalladiumIBA
07/2013
1RutheniumIBA
07/2013
1Protons (Proton)IBA
07/2013
1Verteporfin (Visudyne)FDA Link
05/2013
11-phenyl-3,3-dimethyltriazene (PDT)IBA
05/2013
1TAK 733IBA
04/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2011
1tremelimumabIBA
10/2009
1Dihydrotachysterol (AT 10)IBA
10/2009
1Triamcinolone (Aristocort)FDA Link
05/2009
1Bevacizumab (Avastin)FDA Link
05/2009
1Retinal Pigments (Pigments, Visual)IBA
01/2009
1Furosemide (Lasix)FDA LinkGeneric
01/2009

Therapy/Procedure

24Brachytherapy
01/2022 - 05/2009
7Vitrectomy
01/2022 - 06/2014
7Therapeutics
10/2019 - 09/2010
3Radiotherapy
01/2022 - 11/2011
2Aftercare (After-Treatment)
01/2022 - 11/2013
2Drug Therapy (Chemotherapy)
10/2019 - 01/2009
2Ligation
04/2018 - 12/2017
1Drug Tapering
02/2019
1Scleral Buckling
01/2017
1Cell- and Tissue-Based Therapy (Cell Therapy)
05/2014
1Induced Hyperthermia (Thermotherapy)
07/2013
1Photochemotherapy (Photodynamic Therapy)
05/2013
1Molecular Targeted Therapy
05/2013
1Intravitreal Injections
06/2011
1Endotamponade
07/2010
1Lasers (Laser)
05/2009
1Light Coagulation
05/2009